Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review
- PMID: 22575237
- DOI: 10.1016/j.parkreldis.2012.04.005
Muscle selection for treatment of cervical dystonia with botulinum toxin--a systematic review
Abstract
Rationale: Cervical dystonia, also called spasmodic torticollis, is the most common form of (primary) dystonia. Intramuscular injections with botulinum toxin are the first line of treatment for cervical dystonia. To optimise the treatment response to botulinum toxin correct muscles should be selected. Clinical evaluation is important for muscle selection but the value of additional tests to identify dystonic muscles remains unclear.
Objective: To evaluate all relevant literature regarding the best approach to select dystonic muscles for treatment with botulinum toxin.
Methods: We conducted a systematic review of studies that had investigated methods of selecting muscles for treatment with botulinum toxin. In addition, we compared all prospective botulinum toxin trials using either clinical evaluation or polymyographic electromyography for muscle selection.
Results: Forty relevant studies were included and polymyographic electromyography recordings were most often employed. In several studies, polymyographic electromyography revealed a different pattern of muscle involvement compared to that found during clinical evaluation. In one randomized controlled trial polymyographic electromyography significantly improved the outcome of botulinum toxin treatment. A limited number of studies used positron emission tomography -computed tomography imaging or frequency analysis of the electromyography signal to identify dystonic muscles but their effect on the outcome of treatment has never been studied.
Conclusion: Polymyographic electromyography may improve the outcome of botulinum toxin treatment in cervical dystonia, but evidence is limited and larger studies are needed.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004315. doi: 10.1002/14651858.CD004315.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2016 May 13;(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. PMID: 15674941 Updated.
-
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2016 Oct 26;10(10):CD004314. doi: 10.1002/14651858.CD004314.pub3. Cochrane Database Syst Rev. 2016. PMID: 27782297 Free PMC article.
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633. doi: 10.1002/14651858.CD003633.pub4. PMID: 29230798 Free PMC article. Updated.
-
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004314. doi: 10.1002/14651858.CD004314.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2016 Oct 26;10:CD004314. doi: 10.1002/14651858.CD004314.pub3. PMID: 15674940 Updated.
-
Botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2016 May 13;2016(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. Cochrane Database Syst Rev. 2016. PMID: 27176573 Free PMC article.
Cited by
-
Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review.Life (Basel). 2025 Jun 6;15(6):920. doi: 10.3390/life15060920. Life (Basel). 2025. PMID: 40566572 Free PMC article. Review.
-
Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial.PLoS One. 2015 Apr 29;10(4):e0124937. doi: 10.1371/journal.pone.0124937. eCollection 2015. PLoS One. 2015. PMID: 25923718 Free PMC article. Clinical Trial.
-
Doses of Botulinum Toxin in Cervical Dystonia: Does Ultrasound Guidance Change Injection Practices?Toxins (Basel). 2024 Oct 11;16(10):439. doi: 10.3390/toxins16100439. Toxins (Basel). 2024. PMID: 39453215 Free PMC article.
-
Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance.Neurol Clin Pract. 2019 Feb;9(1):64-73. doi: 10.1212/CPJ.0000000000000568. Neurol Clin Pract. 2019. PMID: 30859009 Free PMC article. Review.
-
Botulinum Toxin in Movement Disorders: An Update.Toxins (Basel). 2021 Jan 8;13(1):42. doi: 10.3390/toxins13010042. Toxins (Basel). 2021. PMID: 33430071 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources